Product Description
Noggin belongs to a group of diffusible proteins which bind to ligands of the TGF- family and regulate their activity by inhibiting their access to signaling receptors. Noggin was originally identified as a BMP-4 antagonist whose action is critical for proper formation of the head and other dorsal structures. Consequently, Noggin has been shown to modulate the activities of other BMPs including BMP-2,-7,-13, and -14. Targeted deletion of Noggin in mice results in prenatal death and recessive phenotype displaying a severely malformed skeletal system. Conversely, transgenic mice over-expressing Noggin in mature osteoblasts display impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis. Recombinant human Noggin is a 23.1 kDa non-disulfide-linked homodimer consisting of a total of 206 amino acid residues.
Biovision | 4675 | Noggin human recombinant DataSheet
Biomolecule/Target: N/A
Synonyms: none
Alternates names:
Taglines: An inhibitor of TGF- signal transduction
NCBI Gene ID #:
NCBI Gene Symbol:
Gene Source: N/A
Accession #:
Recombinant: Yes
Source:
Purity by SDS-PAGEs:
Assay:
Purity:
Assay #2:
Endotoxin Level:
Activity (Specifications/test method):
Biological activity:
Results:
Binding Capacity: N/A
Unit Definition:
Molecular Weight:
Concentration:
Appearance: Lyophilized protein
Physical form description:
Reconstitution Instructions:
Amino acid sequence: